ConductScience.org, home

Paper29134585

Practical Advice on the One-Step Growth Curve.

Kropinski AM. Methods Mol Biol, 2018. Cited by 182 papers, by iCite.

Cite this record

ConductScience Library. Practical Advice on the One-Step Growth Curve. Papers, record 29134585. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29134585

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Practical Advice on the One-Step Growth Curve.
PubMed
Journal
Methods Mol Biol
PubMed
Year
2018
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
182
iCite
Relative citation ratio, by iCite
9.35
iCite
Revised in PubMed
2018-09-10
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kropinski AMAndrew M

Source PubMed

Download CSV of authors

Topics4

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BacteriophagesMajor topic
Microbiological TechniquesMajor topic
Bacteria
Statistics as Topic

Cited by148

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 182 citations.

PMIDTitleJournalYearIn PapersSource
42972195Characterization of phage Henuyfy19N against Pseudomonas aeruginosa and its efficacy in animal models.AMB Express2026https://conductscience.org/library/papers/42972195PubMed
42698769Detachable dissolving microneedles loaded with Silviavirus phage Pelagios enhance antibacterial efficacy against methicillin resistant Staphylococcus aureus in ex vivo porcine skin.Front Microbiol2026https://conductscience.org/library/papers/42698769PubMed
42690138Phage vB_KpnM_NB cocktail synergizing with amikacin in inhibiting persister cells of Klebsiella pneumoniae.Appl Environ Microbiol2026https://conductscience.org/library/papers/42690138PubMed
42687318Genomic and Phenotypic Characterization of Two Novel Enterobacter Phages With EDTA-Enhanced Antibiofilm Activity.Microbiologyopen2026https://conductscience.org/library/papers/42687318PubMed
42687099Natural occurrence of a slow lytic pseudomonas phage in a Pediatric case of multidrug-resistant P. aeruginosa severe pneumonia.Virus Genes2026https://conductscience.org/library/papers/42687099PubMed
42473042Genomic characterization and therapeutic potential of five broad-spectrum lytic bacteriophages against multidrug-resistant avian pathogenic Escherichia coli (APEC).Microbiol Spectr2026https://conductscience.org/library/papers/42473042PubMed
42353228A Novel Lytic Podovirus AP-20-A Infecting Sinorhizobium meliloti: Mosaic Genome with Cross-Phylum Homology and Implications for Inoculant Establishment.Int J Mol Sci2026https://conductscience.org/library/papers/42353228PubMed
42239221Single amino acid substitution in DNA Polymerase I dramatically alters infection dynamics of bacteriophage T7.bioRxiv2026https://conductscience.org/library/papers/42239221PubMed
42151807Isolation and characterization of novel bacteriophage, vB_AbaA_SWMUZ8, targeting multidrug-resistant Acinetobacter baumannii strains.BMC Microbiol2026https://conductscience.org/library/papers/42151807PubMed
42112428Characterization and genomic analysis of DSF2: a novel lytic phage infecting multidrug-resistant Shigella.Front Microbiol2026https://conductscience.org/library/papers/42112428PubMed
42075738Antibacterial Efficacy of Pseudomonas aeruginosa Bacteriophages on a Drosophila Infection Model.Pathogens2026https://conductscience.org/library/papers/42075738PubMed
42075174Isolation and Characterization of Two Bacteriophages Infecting Bacillus anthracis: Biological Properties and Genomic Analysis.Microorganisms2026https://conductscience.org/library/papers/42075174PubMed
42059665Synergistic effects of halo-plaque forming phage cocktails against polymicrobial Acinetobacter baumannii and Staphylococcus aureus.Microbiol Spectr2026https://conductscience.org/library/papers/42059665PubMed
42041328Isolation and Characterization of a Klebsiella Phage H33IIK Targeting Multidrug-Resistant Klebsiella pneumoniae in Peru.Antibiotics (Basel)2026https://conductscience.org/library/papers/42041328PubMed
42037381Characterization of novel phage Henuyfy11N: a potential therapeutic agent against extended-spectrum β-lactamase (ESBL)-producing Escherichia coli.Microbiol Spectr2026https://conductscience.org/library/papers/42037381PubMed
41972581Phage Frontiers: Genomic and Functional Profiling of Novel Virulent Agents Targeting Foodborne Enterobacteriaceae.Biology (Basel)2026https://conductscience.org/library/papers/41972581PubMed
41968149Genomic analysis of jumbo coliphage fEgEco12.Arch Virol2026https://conductscience.org/library/papers/41968149PubMed
41935234Rage against the mean: a perspective on measuring fitness of individual phage particles.Npj Viruses2026https://conductscience.org/library/papers/41935234PubMed
41883389Bacteriophage titering by optical density means: KOTE assays.Open Life Sci2025https://conductscience.org/library/papers/41883389PubMed
41882051Comparative morphological, genomic, and functional characterization of two newly isolated lytic caudoviricetes phages targeting Escherichia coli and Salmonella.Sci Rep2026https://conductscience.org/library/papers/41882051PubMed

See all 148 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29134585

GET https://conductscience.org/api/papers/v1/29134585/cited_by?page=2